Acute kidney injury following acute pancreatitis: A review

Biomedical Papers

Volumn 157, Issue 2, 2013, Pages 105-113

  Petejova, Nadezda ^a   Martinek, Arnost ^a  

^a UNIVERSITY OF OSTRAVA   (Czech Republic)

Author keywords

Acute kidney injury; Biomarkers; Blood purification; Intraabdominal hypertension; Multiple organ dysfunction syndrome; Pathophysiology; Renal replacement therapy; Severe acute pancreatitis; Treatment options

Indexed keywords

ACUTE DISEASE; ACUTE KIDNEY FAILURE; ANIMAL; ARTICLE; HUMAN; PANCREATITIS; PATHOPHYSIOLOGY; RAT; RISK FACTOR;

ACUTE DISEASE; ACUTE KIDNEY INJURY; ANIMALS; HUMANS; PANCREATITIS; RATS; RISK FACTORS;

EID: 84879322056     PISSN: 12138118     EISSN: 18047521     Source Type: Journal    
DOI: 10.5507/bp.2013.048     Document Type: Article

References (108)

1. Zhang XP, Zhang L, Chen LJ, Cheng QH, Wang JM, Cai W, Shen HP, Cai J. Influence of dexamethasone on inflammatory mediators and NF-kappaB expression in multiple organs of rats with severe acute pancreatitis. World J Gastroenterol 2007;13(4):548-56.
2. Halonen KI, Leppaniemi AK, Puolakkainen PA, Lundin JE, Kemppainen EA, Hietaranta AJ, Haapiainen RK. Severe acute pancreatitis: prognostic factors in 270 consecutive patients. Pancreas 2000;21(3):266-71.
3. Kes P, Vucicević Z, Ratković-Gusić I, Fotivec A. Acute renal failure complicating severe acute pancreatitis. Ren Fail 1996;18(4):621-8.
4. Tran DD, Oe PL, de Fijter CW, van der Meulen J, Cuesta MA. Acute renal failure in patients with acute pancreatitis: prevalence, risk factors, and outcome. Nephrol Dial Transplant 1993;8(10):1079-84.
5. Takase K, Takeyama Y, Nishikawa J, Ueda T, Hori Y, Yamamoto M, Kuroda Y. Apoptotic cell death of renal tubules in experimental severe acute pancreatitis. Surgery 1999;125(4):411-20.
6. Bellomo R, Kellum JA, Ronco C. Acute kidney injury. Lancet 2012;380(9843):756-66.
7. Schrier RW, Wang W, Poole B, Mitra A. Acute renal failure: definitions, diagnosis, pathogenesis, and therapy. J Clin Invest 2004;114(1):5-14.
8. Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P; Acute Dialysis Quality Initiative workgroup. Acute renal failure definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group.Crit Care 2004;8(4):R204-12.
9. Mehta RL, Kellum JA, Shah SV, Molitoris BA, Ronco C, Warnock DG, Levin A; Acute Kidney Injury Network. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 2007;11(2):R31.
10. Bagshaw SM, George C, Bellomo R; ANZICS Database Management Committe. A comparison of the RIFLE and AKIN criteria for acute kidney injury in critically ill patients. Nephrol Dial Transplant 2008;23(5):1569-74.
11. Bagshaw SM, George C, Dinu I, Bellomo R. A multi-centre evaluation of the RIFLE criteria for early acute kidney injury in critically ill patients. Nephrol Dial Transplant 2008;23(4):1203-10.
12. Kellum JA, Lameire N; for the KDIGO AKI Guideline Work Group. Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1).Crit Care 2013;17(1):204. [Epub ahead of print]
13. Fliser D, Laville M, Covic A, Fouque D, Vanholder R, Juillard L, Van Biesen Wad-hoc working group of ERBP. A European Renal Best Practice (ERBP) position statement on the Kidney Disease Improving Global Outcomes (KDIGO) clinical practice guidelines on acute kidney injury: part 1: definitions, conservative management and contrast-induced nephropathy. Nephrol Dial Transplant 2012;27(12):4263-72.
14. Sarr MG. 2012 revision of the Atlanta Classification of acute pancreatitis. Pol Arch Med Wewn 2013;123(3):118-24.
15. Grönroos JM, Hietaranta AJ, Nevalainen TJ. Renal tubular cell injury and serum phospholipase A2 activity in acute pancreatitis. Br J Surg 1992;79(8):800-1.
16. Zhang XP, Zhang J, Ma ML, Cai Y, Xu RJ, Xie Q, Jiang XG, Ye Q. Pathological changes at early stage of multiple organ injury in a rat model of severe acute pancreatitis. Hepatobiliary Pancreat Dis Int 2010;9(1):83-7.
17. Esrefoglu M. Experimental and clinical evidence of antioxidant therapy in acute pancreatitis. World J Gastroenterol 2012;18(39):5533-41.
18. Price PM, Safirstein RL, Megyesi J. The cell cycle and acute kidney injury. Kidney Int 2009;76(6):604-13.
19. López Martín A, Carrillo Alcaraz A. Oxidative stress and acute pancreatitis. Rev Esp Enferm Dig 2011;103(11):559-62.
20. Pupelis G, Plaudis H, Zeiza K, Drozdova N, Mukans M, Kazaka I. Early continuous veno-venous haemofiltration in the management of severe acute pancreatitis complicated with intra-abdominal hypertension: retrospective review of 10 years' experience. Ann Intensive Care 2012;2 Suppl 1:S21.
21. Li H, Qian Z, Liu Z, Liu X, Han X, Kang H. Risk factors and outcome of acute renal failure in patients with severe acute pancreatitis. J Crit Care 2010;25(2):225-9.
22. Caldwell CB, Ricotta JJ. Evaluation of intra-abdominal pressure and renal hemodynamics. Curr Surg 1986;43(6):495-8.
23. De Waele JJ, De Laet I, Kirkpatrick AW, Hoste E. Intra-abdominal Hypertension and Abdominal Compartment Syndrome. Am J Kidney Dis 2011;57(1):159-69.
24. Cheatham ML, Malbrain ML, Kirkpatrick A, Sugrue M, Parr M, De Waele J, Balogh Z, Leppäniemi A, Olvera C, Ivatury R, D'Amours S, Wendon J, Hillman K, Wilmer A. Results from the International Conference of Experts on Intra-abdominal Hypertension and Abdominal Compartment Syndrome. II. Recommendations. Intensive Care Med 2007;33(6):951-62.
25. Cheatham ML. Abdominal compartment syndrome: patho physiology and definitions. Scand J Trauma Resusc Emerg Med 2009;17:10.
26. Farge D, De la Coussaye JE, Beloucif S, Fratacci MD, Payen DM. Interactions between hemodynamic and hormonal modifications during PEEP-induced antidiuresis and antinatriuresis. Chest 1995;107(4):1095-100.
27. Mohmand H, Goldfarb S. Renal dysfunction associated with intra-abdominal hypertension and the abdominal compartment syndrome. J Am Soc Nephrol 2011;22(4):615-21.
28. Aspesi M, Gamberoni C, Severgnini P, Colombo G, Chiumello D, Minoja G, Tulli G, Malacrida R, Pelosi P, Chiaranda M. The abdominal compartment syndrome. Clinical relevance. Minerva Anestesiol 2002;68(4):138-46.
29. Dalfino L, Tullo L, Donadio I, Malcangi V, Brienza N. Intra-abdominal hypertension and acute renal failure in critically ill patients. Intensive Care Med 2008;34(4):707-13.
30. Schachtrupp A, Lawong G, Afify M, Graf J, Toens C, Schumpelick V. Fluid resuscitation preserves cardiac output but cannot prevent organ damage in a porcine model during 24 h of intraabdominal hypertension. Shock 2005;24(2):153-8.
31. Bloomfield GL, Blocher CR, Fakhry IF, Sica DA, Sugerman HJ. Elevated intra-abdominal pressure increases plasma renin activity and aldosterone levels. J Trauma 1997;42(6):997-1004.
32. Shenasky JH 2nd. The renal hemodynamic and functional effects of external counterpressure. Surg Gynecol Obstet 1972;134(2):253-8.
33. Agarwal N, Pitchumoni CS. Acute pancreatitis: a multisystem disease. Gastroenterologist 1993;1(2):115-28.
34. Lembeck F, Griesbacher T. Pathophysiological and possible physiological roles of kinins in the pancreas. Immunopharmacology 1996;33(1-3):336-8.
35. Bonventre JV. Diagnosis of acute kidney injury: from classic parameters to new biomarkers. Contrib Nephrol 2007;156:213-9.
36. Bellomo R, Kellum JA, Ronco C. Defining acute renal failure: physiological principles. Intensive Care Med 2004;30(1):33-7.
37. Xue JL, Daniels F, Star RA, Kimmel PL, Eggers PW, Molitoris BA, Himmelfarb J, Collins AJ. Incidence and mortality of acute renal failure in Medicare beneficiaries, 1992 to 2001. J Am Soc Nephrol 2006;17(4):1135-42.
38. Hoste EA, Lameire NH, Vanholder RC, Benoit DD, Decruyenaere JM, Colardyn FA. Acute renal failure in patients with sepsis in a surgical ICU: predictive factors, incidence, comorbidity, and outcome. J Am Soc Nephrol 2003;14(4):1022-30.
39. Uchino S, Kellum JA, Bellomo R, Doig GS, Morimatsu H, Morgera S, Schetz M, Tan I, Bouman C, Macedo E, Gibney N, Tolwani A, Ronco C; Beginning and Ending Supportive Therapy for the Kidney (BEST Kidney) Investigators. Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA 2005 17;294(7):813-8.
40. Himmelfarb J, Joannidis M, Molitoris B, Schietz M, Okusa MD, Warnock D, Laghi F, Goldstein SL, Prielipp R, Parikh CR, Pannu N, Lobo SM, Shah S, D'Intini V, Kellum JA. Evaluation and initial management of acute kidney injury. Clin J Am Soc Nephrol 2008;3(4):962-7.
41. Chertow GM, Burdick E, Honour M, Bonventre JV, Bates DW. Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol 2005;16(11):3365-70.
42. Bagshaw SM, Bellomo R. Urine abnormalities in acute kidney injury and sepsis. Contrib Nephrol 2010;165:274-83.
43. Bagshaw SM, Langenberg C, Bellomo R. Urinary biochemistry and microscopy in septic acute renal failure: systematic review. Am J Kidney Dis 2006;48(5):695-705.
44. Carvounis CP, Nisar S, Guro-Razuman S. Significance of the fractional excretion of urea in the differential diagnosis of acute renal failure. Kidney Int 2002;62(6):2223-9.
45. Perazella MA, Coca SG, Kanbay M, Brewster UC, Parikh CR. Diagnostic value of urine microscopy for differential diagnosis of acute kidney injury in hospitalized patients. Clin J Am Soc Nephrol 2008;3(6):16159.
46. Bagshaw SM, Langenberg C, Haase M, Wan L, May CN, Bellomo R. Urinary biomarkers in septic acute kidney injury. Intensive Care Med 2007;33(7):1285-96.
47. Kokot M, Biolik G, Ziaja D, Fojt T, Cisak K, Antoniak K, Kowalewska-Twardela T, Pawlicki K, Ziaja K, Dulawa J. Acute kidney injury after abdominal aortic aneurysm surgery: detailed assessment of early effects using novel markers. Pol Arch Med Wewn 2012;122(7-8):353-60.
48. Nejat M, Pickering JW, Devarajan P, Bonventre JV, Edelstein CL, Walker RJ, Endre ZH. Some biomarkers of acute kidney injury are increased in pre-renal acute injury. Kidney Int 2012;81(12):1254-62.
49. Cho E, Yang HN, Jo SK, Cho WY, Kim HK. The role of urinary liver-type fatty acid-binding protein in critically ill patients. J Korean Med Sci 2013;28(1):100-5.
50. Dent CL, Ma Q, Dastrala S, Bennett M, Mitsnefes MM, Barasch J, Devarajan P. Plasma neutrophil gelatinase-associated lipocalin predicts acute kidney injury, morbidity and mortality after pediatric cardiac surgery: a prospective uncontrolled cohort study. Crit Care 2007;11(6):R127.
51. Han WK, Waikar SS, Johnson A, Betensky RA, Dent CL, Devarajan P, Bonventre JV. Urinary biomarkers in the early diagnosis of acute kidney injury. Kidney Int 2008;73(7):863-9.
52. Belcher JM, Edelstein CL, Parikh CR.Clinical applications of biomarkers for acute kidney injury. Am J Kidney Dis 2011;57(6):930-40.
53. Devarajan P. Emerging biomarkers of acute kidney injury. Contrib Nephrol 2007;156:203-12.
54. Parikh CR, Edelstein CL, Devarajan P, Cantley L. Biomarkers of acute kidney injury: early diagnosis, pathogenesis, and recovery. J Investig Med 2007;55(7):333-40.
55. Kashani K, Al-Khafaji A, Ardiles T, Artigas A, Bagshaw SM, Bell M, Bihorac A, Birkhahn R, Cely CM, Chawla LS, Davison DL, Feldkamp T, Forni LG, Gong MN, Gunnerson KJ, Haase M, Hackett J, Honore PM, Hoste EA, Joannes-Boyau O, Joannidis M, Kim P, Koyner JL, Laskowitz DT, Lissauer ME, Marx G, McCullough PA, Mullaney S, Ostermann M, Rimmelé T, Shapiro NI, Shaw AD, Shi J, Sprague AM, Vincent JL, Vinsonneau C, Wagner L, Walker MG, Wilkerson RG, Zacharowski K, Kellum JA. Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury. Crit Care 2013;17(1):R25.
56. Hong DY, Lee JH, Park SO, Je Baek K, Lee KR. Plasma Neutrophil Gelatinase-associated Lipocalin as Early Biomarker for Acute Kidney Injury in Burn Patients. J Burn Care Res 2013 Mar 18. [Epub ahead of print]
57. Martino FK, Filippi I, Giavarina D, Kaushik M, Rodighiero MP, Crepaldi C, Teixeira C, Nadal AF, Rosner MH, Ronco C. Neutrophil gelatinaseassociated lipocalin in the early diagnosis of peritonitis: the case of neutrophil gelatinase-associated lipocalin. Contrib Nephrol 2012;178:258-63.
58. Koyner JL, Garg AX, Shlipak MG, Patel UD, Sint K, Hong K, Devarajan P, Edelstein CL, Zappitelli M, Thiessen-Philbrook H, Parikh CR; Translational Research Investigating Biomarker Endpoints in AKI (TRIBE AKI) Consortium. Urinary Cystatin C and Acute Kidney Injury After Cardiac Surgery. Am J Kidney Dis 2013 Jan 15 [Epub ahead of print] doi:10.1053/j.ajkd.2012.12.006
59. Zhang Z, Ni H, Lu B, Jin N. Elevated serum Cystatin C at continuous renal replacement therapy initiation predicts lack of renal recovery. Clin Nephrol 2013 Jan 15. [Epub ahead of print]
60. Coppolino G, Presta P, Saturno L, Fuiano G. Acute kidney injury in patients undergoing cardiac surgery. J Nephrol 2013;26(1):32-40.
61. Lee DW, Faubel S, Edelstein CL. Cytokines in acute kidney injury (AKI). Clin Nephrol 2011;76(3):165-73.
62. Zhu HH, Jiang LL. Serum inter-cellular adhesion molecule 1 is an early marker of diagnosis and prediction of severe acute pancreatitis. World J Gastroenterol 2012;18(20):2554-60.
63. Jiang K, Huang W, Yang XN, Xia Q. Present and future of prophylactic antibiotics for severe acute pancreatitis. World J Gastroenterol 2012;18(3):279-84.
64. Nicholson LJ. Acute pancreatitis: should we use antibiotics? Curr Gastroenterol Rep 2011;13(4):336-43.
65. Anand N, Park JH, Wu BU. Modern management of acute pancreatitis. Gastroenterol Clin North Am 2012;41(1):1-8.
66. Takeda K, Takada T, Kawarada Y, Hirata K, Mayumi T, Yoshida M, Sekimoto M, Hirota M, Kimura Y, Isaji S, Koizumi M, Otsuki M, Matsuno S; JPN. JPN Guidelines for the management of acute pancreatitis: medical management of acute pancreatitis. J Hepatobiliary Pancreat Surg 2006;13(1):42-7.
67. Doctor N, Agarwal P, Gandhi V. Management of severe acute pancreatitis. Indian J Surg 2012;74(1):40-6.
68. Zhang XP, Zhang L, Wang Y, Cheng QH, Wang JM, Cai W, Shen HP, Cai J. Study of the protective effects of dexamethasone on multiple organ injury in rats with severe acute pancreatitis. JOP 2007;8(4):400-12.
69. Le Campion ER, Jukemura J, Coelho AM, Patzina R, Carneiro D'Albuquerque LA. Effects of intravenous administration of pentoxifylline in pancreatic ischaemia-reperfusion injury. HPB (Oxford) 2012 Dec 17. [Epub ahead of print] doi: 10.1111/hpb.12013.
70. Du XG, Chen XM, Gan H, Li ZR, Wen YJ, Wang XC. Continuous blood purification ameliorates RhoA-mediated endothelial permeability in severe acute pancreatitis patients with lung injury. Int J Artif Organs 2011;34(4):348-56.
71. Wang S, Xu L, Feng X, Li S, Feng Q, Liu C, Zhang X, Zhao Q. Is Continuous Venovenous Hemofiltration Effective Against Severe Acute Pancreatitis? Artif Organs 2013 Mar 5. [Epub ahead of print] doi: 10.1111/aor.12051.
72. Gong D, Zhang P, Ji D, Chen Z, Li W, Li J, Li L, Liu Z. Improvement of immune dysfunction in patients with severe acute pancreatitis by high-volume hemofiltration: a preliminary report. Int J Artif Organs 2010;33(1):22-9.
73. Chu LP, Zhou JJ, Yu YF, Huang Y, Dong WX. Clinical effects of pulse high-volume hemofiltration on severe acute pancreatitis complicated with multiple organ dysfunction syndrome. Ther Apher Dial 2013;17(1):78-83.
74. Zhu Y, Yuan J, Zhang P, Hu X, He Q, Han F, Chen J. Adjunctive continuous high-volume hemofiltration in patients with acute severe pancreatitis: a prospective nonrandomized study. Pancreas 2011;40(1)109-13.
75. Yang C, Guanghua F, Wei Z, Zhong J, Penghui J, Xin F, Xiping Z. Combination of hemofiltration and peritoneal dialysis in the treatment of severe acute pancreatitis. Pancreas 2010;39(1):16-9.
76. Yu C, Liu ZH, Chen ZH, Gong DH, Ji DX, Li LS. Improvement of monocyte function and immune homeostasis by high volume continuous venovenous hemofiltration in patients with severe acute pancreatitis. Int J Artif Organs 2008;31(10):882-90.
77. Pupelis G, Plaudis H, Grigane A, Zeiza K, Purmalis G. Continuous veno-venous haemofiltration in the treatment of severe acute pancreatitis: 6-year experience. HPB (Oxford) 2007;9(4):295-301.
78. Chen ZH, Liu ZH, Yu C, Ji DX, Li LS. Endothelial dysfunction in patients with severe acute pancreatitis: improved by continuous blood purification therapy. Int J Artif Organs 2007;30(5):393-400.
79. Jiang HL, Xue WJ, Li DQ, Yin AP, Xin X, Li CM, Gao JL. Influence of continuous veno-venous hemofiltration on the course of acute pancreatitis. World J Gastroenterol 2005;11(31):4815-21.
80. Oda S, Hirasawa H, Shiga H, Matsuda K, Nakamura M, Watanabe E, Moriguchi T. Management of intra-abdominal hypertension in patients with severe acute pancreatitis with continuous hemodiafiltration using a polymethyl methacrylate membrane hemofilter. Ther Apher Dial 2005;9(4):355-61.
81. Wang H, Li WQ, Zhou W, Li N, Li JS. Clinical effects of continuous high volume hemofiltration on severe acute pancreatitis complicated with multiple organ dysfunction syndrome. World J Gastroenterol 2003;9(9):2096-9.
82. Xie H, Ji D, Gong D, Liu Y, Xu B, Zhou H, Liu Z, Li L, Li W, Quan Z, Li J. Continuous veno-venous hemofiltration in treatment of acute necrotizing pancreatitis. Chin Med J (Engl). 2003;116(4):549-53.
83. Leppäniemi A, Johansson K, De Waele JJ. Abdominal compartment syndrome and acute pancreatitis. Acta Clin Belg Supp. 2007;(1):131-5.
84. Malbrain ML, Chiumello D, Pelosi P, Wilmer A, Brienza N, Malcangi V, Bihari D, Innes R, Cohen J, Singer P, Japiassu A, Kurtop E, De Keulenaer BL, Daelemans R, Del Turco M, Cosimini P, Ranieri M, Jacquet L, Laterre PF, Gattinoni LPrevalence of intra-abdominal hypertension in critically ill patients: a multicentre epidemiological study. Intensive Care Med 2004;30(5):822-9.
85. Malbrain ML, Deeren DH. Effect of bladder volume on measured intravesical pressure: a prospective cohort study. Crit Care 2006;10(4):R98.
86. Malbrain ML, Jones F. Intra-Abdominal pressure measurement techniques. In: Ivatury RR, Cheatham ML, Malbrain ML, Sugrue M. Abdominal compartment syndrome. Georgetown USA: Landes Bioscience 2006; p. 20-68.
87. Desie N, Willems A, De Laet I, Dits H, Van Regenmortel N, Schoonheydt K, Van De Vyvere M, Malbrain ML. Intra-abdominal pressure measurement using the Foley Manometer does not increase the risk for urinary tract infection in critically ill patients. Ann Intensive Care 2012;2 Suppl 1:S10.
88. McBeth PB, Zengerink I, Zygun D, Ranson K, Anderson I, Lall RN, Kirkpatrick AW. Comparison of intermittent and continuous intraabdominal pressure monitoring using an in vitro model. Int J Clin Pract 2008;62(3):400-5.
89. De Waele JJ, Hoste E, Blot SI, Decruyenaere J, Colardyn F. Intraabdominal hypertension in patients with severe acute pancreatitis. Crit Care 2005;9(4):R452-7.
90. Plaudis H, Rudzats A, Melberga L, Kazaka I, Suba O, Pupelis G. Abdominal negative-pressure therapy: a new method in countering abdominal compartment and peritonitis prospective study and critical review of literature. Ann Intensive Care 2012;2 Suppl 1:S23.
91. Haldipur N, Cooper B, Sanyal S. Managing the open abdomen. J R Army Med Corps 2006;152(3):143-7.
92. Björck M, Bruhin A, Cheatham M, Hinck D, Kaplan M, Manca G, Wild T, Windsor A. Classification--important step to improve management of patients with an open abdomen. World J Surg 2009;33(6):1154-7.
93. Boele van Hensbroek P, Wind J, Dijkgraaf MG, Busch OR, Goslings JC. Temporary closure of the open abdomen: a systematic review on delayed primary fascial closure in patients with an open abdomen. World J Surg 2009;33(2):199-207.
94. Balogh Z, McKinley BA, Cocanour CS, Kozar RA, Valdivia A, Sailors RM, Moore FA. Supranormal trauma resuscitation causes more cases of abdominal compartment syndrome. Arch Surg 2003;138(6):637-42.
95. Peng ZY, Critchley LA, Joynt GM, Gruber PC, Jenkins CR, Ho AM. Effects of norepinephrine during intra-abdominal hypertension on renal blood flow in bacteremic dogs. Crit Care Med 2008;36(3):834-41.
96. Bellomo R, Kellum JA, Wisniewski SR, Pinsky MR. Bellomo R, Kellum JA, Wisniewski SR, Pinsky MR. Effects of norepinephrine on the renal vasculature in normal and endotoxemic dogs. Am J Respir Crit Care Med 1999;159(4 Pt 1):1186-92.
97. Albert M, Losser MR, Hayon D, Faivre V, Payen D. Systemic and renal macroand microcirculatory responses to arginine vasopressin in endotoxic rabbits. Crit Care Med 2004;32(9):1891-8.
98. Desjars P, Pinaud M, Potel G, Tasseau F, Touze MD. A reappraisal of norepinephrine therapy in human septic shock. Crit Care Med 1987;15(2):134-7.
99. Hesselvik JF, Brodin B. Low dose norepinephrine in patients with septic shock and oliguria: effects on afterload, urine flow, and oxygen transport. Crit Care Med 1989;17(2):179-80.
100. Hollenberg SM. Vasopressor support in septic shock. Chest 2007;132(5):1678-87.
101. Yuengsrigul A, Chin TW, Nussbaum E. Immunosuppressive and cytotoxic effects of furosemide on human peripheral blood mononuclear cells. Ann Allergy Asthma Immunol 1999;83(6 Pt 1):559-66.
102. Bagshaw SM, Bellomo R, Kellum JA. Oliguria, volume overload, and loop diuretics. Crit Care Med 2008;36(4 Suppl):S172-8.
103. Glassford NJ, Bellomo R. Acute kidney injury: Fluid therapy in acute kidney injury: the FACTTs. Nat Rev Nephrol 2011;7(6):305-6.
104. Zhang XP, Tian H, Lai YH, Chen L, Zhang L, Cheng QH, Yan W, Li Y, Li QY, He Q, Wang F. Protective effects and mechanisms of Baicalin and octreotide on renal injury of rats with severe acute pancreatitis. World J Gastroenterol 2007;13(38): 5079-89.
105. Oudemans-van Straaten HM, Kellum JA, Bellomo R. Clinical review: anticoagulation for continuous renal replacement therapy-heparin or citrate? Crit Care 2011;15(1):202.
106. Uehlinger DE, Jakob SM, Ferrari P, Eichelberger M, Huynh-Do U, Marti HP, Mohaupt MG, Vogt B, Rothen HU, Regli B, Takala J, Frey FJ. Comparison of continuous and intermittent renal replacement therapy for acute renal failure. Nephrol Dial Transplant 2005;20(8):1630-7.
107. Palevsky PM, Zhang JH, O'Connor TZ, Chertow GM, Crowley ST, Choudhury D, Finkel K, Kellum JA, Paganini E, Schein RM, Smith MW, Swanson KM, Thompson BT, Vijayan A, Watnick S, Star RA, Peduzzi P. VA/NIH Acute Renal Failure Trial Network. Intensity of renal support in critically ill patients with acute kidney injury. N Engl J Med 2008;359(1):7-20.
108. Uchino S. What is 'BEST' RRT practice? Contrib Nephrol 2010;165:244-50.